Aksh Optifibre Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 13, 2025, 8:06 pm

Competitors of Aksh Optifibre Ltd

All Competitor Stocks of Aksh Optifibre Ltd

Quarterly Result

Last Updated: August 20, 2025, 2:05 pm

Below is a detailed analysis of the quarterly data for Aksh Optifibre Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 26.95 Cr.. The value appears to be declining and may need further review. It has decreased from 32.98 Cr. (Mar 2025) to 26.95 Cr., marking a decrease of 6.03 Cr..
• For Expenses, as of Jun 2025, the value is 27.87 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 32.87 Cr. (Mar 2025) to 27.87 Cr., marking a decrease of 5.00 Cr..
• For Operating Profit, as of Jun 2025, the value is -0.92 Cr.. The value appears to be declining and may need further review. It has decreased from 0.11 Cr. (Mar 2025) to -0.92 Cr., marking a decrease of 1.03 Cr..
• For OPM %, as of Jun 2025, the value is -3.41%. The value appears to be declining and may need further review. It has decreased from 0.33% (Mar 2025) to -3.41%, marking a decrease of 3.74%.
• For Other Income, as of Jun 2025, the value is -0.71 Cr.. The value appears to be declining and may need further review. It has decreased from 1.72 Cr. (Mar 2025) to -0.71 Cr., marking a decrease of 2.43 Cr..
• For Interest, as of Jun 2025, the value is 3.03 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 5.60 Cr. (Mar 2025) to 3.03 Cr., marking a decrease of 2.57 Cr..
• For Depreciation, as of Jun 2025, the value is 3.01 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 4.42 Cr. (Mar 2025) to 3.01 Cr., marking a decrease of 1.41 Cr..
• For Profit before tax, as of Jun 2025, the value is -7.67 Cr.. The value appears strong and on an upward trend. It has increased from -8.19 Cr. (Mar 2025) to -7.67 Cr., marking an increase of 0.52 Cr..
• For Tax %, as of Jun 2025, the value is -15.78%. The value appears to be increasing, which may not be favorable. It has increased from -18.80% (Mar 2025) to -15.78%, marking an increase of 3.02%.
• For Net Profit, as of Jun 2025, the value is -6.46 Cr.. The value appears strong and on an upward trend. It has increased from -6.65 Cr. (Mar 2025) to -6.46 Cr., marking an increase of 0.19 Cr..
• For EPS in Rs, as of Jun 2025, the value is -0.40. The value appears strong and on an upward trend. It has increased from -0.41 (Mar 2025) to -0.40, marking an increase of 0.01.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: August 22, 2025, 5:20 pm

Growth

Last Updated: September 4, 2025, 10:40 pm

Balance Sheet

Last Updated: November 9, 2025, 1:35 pm

Below is a detailed analysis of the balance sheet data for Aksh Optifibre Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2025, the value is 81.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 81.00 Cr..
• For Reserves, as of Sep 2025, the value is -83.00 Cr.. The value appears to be worsening (becoming more negative). It has deteriorated from -70.00 Cr. (Mar 2025) to -83.00 Cr., marking a decline of 13.00 Cr..
• For Borrowings, as of Sep 2025, the value is 100.00 Cr.. The value appears to be increasing, which may not be favorable. However, Reserves are negative, which is a major warning sign. It has increased from 99.00 Cr. (Mar 2025) to 100.00 Cr., marking an increase of 1.00 Cr..
• For Other Liabilities, as of Sep 2025, the value is 184.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 171.00 Cr. (Mar 2025) to 184.00 Cr., marking an increase of 13.00 Cr..
• For Total Liabilities, as of Sep 2025, the value is 282.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 282.00 Cr..
• For Fixed Assets, as of Sep 2025, the value is 106.00 Cr.. The value appears to be declining and may need further review. It has decreased from 111.00 Cr. (Mar 2025) to 106.00 Cr., marking a decrease of 5.00 Cr..
• For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
• For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
• For Other Assets, as of Sep 2025, the value is 176.00 Cr.. The value appears strong and on an upward trend. It has increased from 171.00 Cr. (Mar 2025) to 176.00 Cr., marking an increase of 5.00 Cr..
• For Total Assets, as of Sep 2025, the value is 282.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 282.00 Cr..

However, the Borrowings (100.00 Cr.) are higher than the Reserves (-83.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Aksh Optifibre Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 5.00.
• For Basic EPS (Rs.), as of Mar 25, the value is -1.60. This value is below the healthy minimum of 5. It has increased from -4.38 (Mar 24) to -1.60, marking an increase of 2.78.
• For Diluted EPS (Rs.), as of Mar 25, the value is -1.60. This value is below the healthy minimum of 5. It has increased from -4.38 (Mar 24) to -1.60, marking an increase of 2.78.
• For Cash EPS (Rs.), as of Mar 25, the value is -0.76. This value is below the healthy minimum of 3. It has increased from -3.08 (Mar 24) to -0.76, marking an increase of 2.32.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is -0.43. It has decreased from 1.34 (Mar 24) to -0.43, marking a decrease of 1.77.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 0.71. It has decreased from 2.49 (Mar 24) to 0.71, marking a decrease of 1.78.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 7.99. It has decreased from 13.54 (Mar 24) to 7.99, marking a decrease of 5.55.
• For PBDIT / Share (Rs.), as of Mar 25, the value is -0.21. This value is below the healthy minimum of 2. It has increased from -2.81 (Mar 24) to -0.21, marking an increase of 2.60.
• For PBIT / Share (Rs.), as of Mar 25, the value is -1.05. This value is below the healthy minimum of 0. It has increased from -4.12 (Mar 24) to -1.05, marking an increase of 3.07.
• For PBT / Share (Rs.), as of Mar 25, the value is -1.68. This value is below the healthy minimum of 0. It has increased from -4.61 (Mar 24) to -1.68, marking an increase of 2.93.
• For Net Profit / Share (Rs.), as of Mar 25, the value is -1.60. This value is below the healthy minimum of 2. It has increased from -4.38 (Mar 24) to -1.60, marking an increase of 2.78.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -1.60. This value is below the healthy minimum of 2. It has increased from -4.38 (Mar 24) to -1.60, marking an increase of 2.78.
• For PBDIT Margin (%), as of Mar 25, the value is -2.69. This value is below the healthy minimum of 10. It has increased from -20.77 (Mar 24) to -2.69, marking an increase of 18.08.
• For PBIT Margin (%), as of Mar 25, the value is -13.11. This value is below the healthy minimum of 10. It has increased from -30.40 (Mar 24) to -13.11, marking an increase of 17.29.
• For PBT Margin (%), as of Mar 25, the value is -20.99. This value is below the healthy minimum of 10. It has increased from -34.08 (Mar 24) to -20.99, marking an increase of 13.09.
• For Net Profit Margin (%), as of Mar 25, the value is -19.96. This value is below the healthy minimum of 5. It has increased from -32.36 (Mar 24) to -19.96, marking an increase of 12.40.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is -19.96. This value is below the healthy minimum of 8. It has increased from -32.36 (Mar 24) to -19.96, marking an increase of 12.40.
• For Return on Networth / Equity (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 15. It has increased from -327.10 (Mar 24) to 0.00, marking an increase of 327.10.
• For Return on Capital Employeed (%), as of Mar 25, the value is -52.50. This value is below the healthy minimum of 10. It has increased from -105.09 (Mar 24) to -52.50, marking an increase of 52.59.
• For Return On Assets (%), as of Mar 25, the value is -9.22. This value is below the healthy minimum of 5. It has increased from -21.47 (Mar 24) to -9.22, marking an increase of 12.25.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Total Debt / Equity (X), as of Mar 25, the value is -11.37. This value is within the healthy range. It has decreased from 3.92 (Mar 24) to -11.37, marking a decrease of 15.29.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.42. It has decreased from 0.61 (Mar 24) to 0.42, marking a decrease of 0.19.
• For Current Ratio (X), as of Mar 25, the value is 0.65. This value is below the healthy minimum of 1.5. It has decreased from 0.76 (Mar 24) to 0.65, marking a decrease of 0.11.
• For Quick Ratio (X), as of Mar 25, the value is 0.59. This value is below the healthy minimum of 1. It has decreased from 0.67 (Mar 24) to 0.59, marking a decrease of 0.08.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.78. This value is within the healthy range. It has increased from 6.19 (Mar 24) to 6.78, marking an increase of 0.59.
• For Interest Coverage Ratio (X), as of Mar 25, the value is -0.25. This value is below the healthy minimum of 3. It has increased from -2.90 (Mar 24) to -0.25, marking an increase of 2.65.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -1.15. This value is below the healthy minimum of 3. It has increased from -4.00 (Mar 24) to -1.15, marking an increase of 2.85.
• For Enterprise Value (Cr.), as of Mar 25, the value is 189.16. It has decreased from 196.40 (Mar 24) to 189.16, marking a decrease of 7.24.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.45. This value is within the healthy range. It has increased from 0.89 (Mar 24) to 1.45, marking an increase of 0.56.
• For EV / EBITDA (X), as of Mar 25, the value is -54.01. This value is below the healthy minimum of 5. It has decreased from -4.29 (Mar 24) to -54.01, marking a decrease of 49.72.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.98. This value is below the healthy minimum of 1. It has increased from 0.59 (Mar 24) to 0.98, marking an increase of 0.39.
• For Price / BV (X), as of Mar 25, the value is -18.20. This value is below the healthy minimum of 1. It has decreased from 6.05 (Mar 24) to -18.20, marking a decrease of 24.25.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.98. This value is below the healthy minimum of 1. It has increased from 0.59 (Mar 24) to 0.98, marking an increase of 0.39.
• For EarningsYield, as of Mar 25, the value is -0.20. This value is below the healthy minimum of 5. It has increased from -0.54 (Mar 24) to -0.20, marking an increase of 0.34.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness